José Francisco Díaz Fernández

Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial

Pascal Vranckx, Marco Valgimigli, Peter Jüni et al. · The Lancet · 2018 · 785 citations · Full text

Medicine, Cardiology, Pharmacotherapy +16

Drug-eluting stents in elderly patients with coronary artery disease (SENIOR): a randomised single-blind trial

Olivier Varenne, Stéphane Cook, Georgios Sidéris et al. · The Lancet · 2017 · 390 citations

Medicine, Cardiology, Geriatric Medicine +12

Radial versus femoral access and bivalirudin versus unfractionated heparin in invasively managed patients with acute coronary syndrome (MATRIX): final 1-year results of a multicentre, randomised controlled trial

Marco Valgimigli, Enrico Frigoli, Sergio Leonardi et al. · The Lancet · 2018 · 300 citations

Medicine, Cardiology, Surgery +17

Ticagrelor in patients with diabetes and stable coronary artery disease with a history of previous percutaneous coronary intervention (THEMIS-PCI): a phase 3, placebo-controlled, randomised trial

Deepak L. Bhatt, Philippe Gabríel Steg, Shamir R Mehta et al. · The Lancet · 2019 · 210 citations · Full text

Medicine, Cardiology, Pharmacotherapy +15

Acute Kidney Injury After Radial or Femoral Access for Invasive Acute Coronary Syndrome Management

Bernardo Cortese, Filippo Russo, Martina Rothenbühler et al. · Journal of the American College of Cardiology · 2017 · 155 citations

Medicine, Cardiology, Surgery +16